Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
International Journal of Clinical Practice
|
June 21, 2005
In response to 'ezetimibe-induced hyperlipidaemia' case report
Harold Bays, Thomas Musliner
Expert Opinion on Pharmacotherapy
|
May 13, 2003
Colesevelam HCl: a non-systemic lipid-altering drug
Harold Bays, Carlos Dujovne
Vascular Health and Risk Management
|
December 15, 2007
Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors
Harold Bays, Peter H Jones
Southern Medical Journal
|
March 13, 2009
Addressing lipid treatment targets beyond cholesterol: a role for prescription omega-3 fatty acid therapy
Tara L Dall, Harold Bays
Current Atherosclerosis Reports
|
March 3, 2006
Adiposopathy is a more rational treatment target for metabolic disease than obesity alone
Harold Bays, Carlos A Dujovne
Expert Opinion on Pharmacotherapy
|
November 5, 2003
Pharmacotherapy for dyslipidaemia--current therapies and future agents
Harold Bays, Evan A Stein
Expert Review of Cardiovascular Therapy
|
September 27, 2005
Torcetrapib/atorvastatin combination therapy
Harold Bays, James McKenney, Michael Davidson
Expert Review of Cardiovascular Therapy
|
December 19, 2006
Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
Harold Bays, Lawrence Blonde, Robert Rosenson
The Physician and Sportsmedicine
|
January 23, 2015
A randomized study of raisins versus alternative snacks on glycemic control and other cardiovascular risk factors in patients with type 2 diabetes mellitus
Harold Bays, Kathy Weiter, James Anderson
Future Cardiology
|
October 7, 2009
Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia
Harold Bays, Nicola Abate, Manisha Chandalia
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
International Journal of Clinical Practice
|
June 21, 2005
In response to 'ezetimibe-induced hyperlipidaemia' case report
Harold Bays, Thomas Musliner
Expert Opinion on Pharmacotherapy
|
May 13, 2003
Colesevelam HCl: a non-systemic lipid-altering drug
Harold Bays, Carlos Dujovne
Vascular Health and Risk Management
|
December 15, 2007
Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors
Harold Bays, Peter H Jones
Southern Medical Journal
|
March 13, 2009
Addressing lipid treatment targets beyond cholesterol: a role for prescription omega-3 fatty acid therapy
Tara L Dall, Harold Bays
Current Atherosclerosis Reports
|
March 3, 2006
Adiposopathy is a more rational treatment target for metabolic disease than obesity alone
Harold Bays, Carlos A Dujovne
Expert Opinion on Pharmacotherapy
|
November 5, 2003
Pharmacotherapy for dyslipidaemia--current therapies and future agents
Harold Bays, Evan A Stein
Expert Review of Cardiovascular Therapy
|
September 27, 2005
Torcetrapib/atorvastatin combination therapy
Harold Bays, James McKenney, Michael Davidson
Expert Review of Cardiovascular Therapy
|
December 19, 2006
Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
Harold Bays, Lawrence Blonde, Robert Rosenson
The Physician and Sportsmedicine
|
January 23, 2015
A randomized study of raisins versus alternative snacks on glycemic control and other cardiovascular risk factors in patients with type 2 diabetes mellitus
Harold Bays, Kathy Weiter, James Anderson
Future Cardiology
|
October 7, 2009
Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia
Harold Bays, Nicola Abate, Manisha Chandalia
Page
of 8